HUM — Recent News Coverage

All news mentioning HUM in ESEN's AI-graded feed

News stories with HUM as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on HUM. See /coverage/HUM for the 30-day aggregate.

12 articles Updated: 2026-08-23 21:09 UTC Filter: Ticker: $HUM
LIVEMINT.COM · 2026-08-12 NEUTRAL BEARISH CORR0.15

Glenmark Pharma US subsidiary agrees to $15.28 million settlement with Humana in generic drug antitrust case

$HUM
◈ ESEN AI
Glenmark Pharma's US subsidiary has settled antitrust litigation with Humana for $15.28 million, resolving allegations of generic drug pricing collusion and market allocation practices. While the settlement amount is ma…
FINANCE.YAHOO.COM · 2026-08-04 NEUTRAL BULLISH CORR0.72

Humana’s (HUM) Path to Recovery and Growth

$HUM
◈ ESEN AI
Humana (HUM) is featured in the context of strong midcap value performance during Q2 2026, with the Russell Midcap Value Index delivering 13.4% returns. This suggests the company benefited from broader market momentum i…
FINANCE.YAHOO.COM · 2026-08-03 NEUTRAL NEUTRAL CORR0.55

Is Humana (HUM) an Undervalued Turnaround Play as Medicare Margins Recover?

$HUM
◈ ESEN AI
Humana (HUM) has emerged as a potential turnaround candidate as Medicare margins show signs of recovery following earlier pressure from medical cost inflation and competitive bidding dynamics. The company's undervaluati…
SEEKINGALPHA.COM · 2026-07-29 NEUTRAL BULLISH CORR0.52

Humana Q2 Earnings Review: Management Tight-Lipped, But Recovery Still On Track (NYSE:HUM)

$HUM
◈ ESEN AI
Humana (HUM) has articulated a medium-term profitability target of 3% pre-tax margin by 2028, signaling management confidence in operational recovery despite current sector headwinds. This guidance reflects a discipline…
SEEKINGALPHA.COM · 2026-07-29 NEUTRAL NEUTRAL CORR0.52

Humana Inc. (HUM) Q2 2026 Earnings Call Transcript

$HUM
◈ ESEN AI
Humana Inc. (HUM) released Q2 2026 earnings results via transcript on July 29, 2026. The earnings call represents management's commentary on operational performance, guidance, and forward-looking strategy. Earnings tran…
CNBC · 2026-07-29 NEUTRAL NEUTRAL CORR0.35

Humana tops quarterly estimates, maintains profit outlook as medical costs stay in line

$HUM
◈ ESEN AI
Humana delivered quarterly earnings above consensus expectations, signaling operational stability in its core medical underwriting business. The maintenance of controlled medical cost trends—a critical metric for health…
RTTNEWS.COM · 2026-07-29 NEUTRAL NEUTRAL CORR0.25

Humana Q2 Profit Climbs, Cuts FY26 EPS Outlook, Backs Adj. Earnings, Revenue View; Stock Down

$HUM
◈ ESEN AI
Humana delivered a mixed earnings surprise: Q2 profitability exceeded expectations with robust revenue expansion, signaling operational strength in core underwriting and membership dynamics. However, the stock declined …
SEEKINGALPHA.COM · 2026-07-15 HIGH BEARISH CORR0.42

Humana: Q2 Earnings Must Catch Up With The Stock (NYSE:HUM)

$HUM
◈ ESEN AI
Humana (HUM) has experienced a dramatic 106% stock price appreciation driven by Medicare Advantage market enthusiasm, yet fundamental metrics suggest the rally has outpaced underlying business performance. The disconnec…
FINANCE.YAHOO.COM · 2026-06-23 NEUTRAL BEARISH CORR0.42

Here’s What Hit Humana (HUM) in Q1

$HUM
◈ ESEN AI
Humana (HUM) faced headwinds during Q1 2026 within a broader equity market environment pressured by geopolitical tensions and sector rotation dynamics. The Iran conflict elevated energy prices, creating cross-asset vola…
INVESTING.COM · 2026-06-18 NEUTRAL BULLISH CORR0.58

3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound

$LLY $HUM $DXCM $JNJ
◈ ESEN AI
Eli Lilly (LLY), Humana (HUM), and DexCom (DXCM) are emerging as key drivers of a healthcare sector rebound, signaling renewed investor confidence in pharmaceutical innovation, managed care platforms, and continuous glu…
FINANCE.YAHOO.COM · 2026-06-15 NEUTRAL BULLISH CORR0.58

Jim Cramer on UnitedHealth: “Buy It”

$UNH $HUM
◈ ESEN AI
UnitedHealth (UNH) received a bullish endorsement from Jim Cramer on Mad Money, framed within a broader rotation into defensive sectors. The analyst highlighted the managed care operator's appeal during a period of mark…
FINANCE.YAHOO.COM · 2026-06-13 NEUTRAL BULLISH CORR0.58

Mizuho Raises its Price Target on Humana (HUM)

$HUM
◈ ESEN AI
Mizuho's price target elevation on HUM reflects analyst conviction in the managed care operator's fundamental trajectory. The 16.4% upside revision—from $335 to $390—suggests improving visibility into earnings sustainab…
EXPLORE OTHER FILTERS